What questions should be asked of a patient with hypothyroidism taking levothyroxine 100 µg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Essential Questions for Patients with Hypothyroidism on Levothyroxine 100 mcg

When evaluating a patient with hypothyroidism taking levothyroxine 100 mcg, you must systematically assess medication adherence, symptom control, potential drug interactions, and factors affecting absorption to optimize therapy and prevent both under- and overtreatment complications.

Medication Administration and Adherence

Timing and Method

  • Are you taking levothyroxine 30-60 minutes before breakfast with water on an empty stomach? 1, 2

    • Alternative: Are you taking it at bedtime, 4 hours after your last meal?
    • This is critical because absorption is significantly reduced when taken with food 1
  • Do you ever miss doses? If yes, how often?

    • Patients on high doses (>200 mcg/d) with persistently elevated TSH are most commonly non-compliant 1
    • Missing doses should be made up when recognized, even on the same or subsequent days 1
  • How are you storing your medication?

    • Must be stored at 20-25°C (68-77°F), protected from light and moisture 1, 2

Interfering Substances

Are you taking any of these within 4 hours of your levothyroxine? 1, 2

  • Iron supplements
  • Calcium supplements
  • Antacids
  • Proton pump inhibitors
  • Multivitamins containing minerals

Other medications that may interfere: 1

  • Estrogen/oral contraceptives
  • Bile acid sequestrants (cholestyramine, colestipol)
  • Soy products
  • Fiber supplements
  • Glucocorticoids
  • Amiodarone
  • Anticonvulsants (phenytoin, carbamazepine)

Symptom Assessment for Treatment Adequacy

Signs of Undertreatment (Persistent Hypothyroidism)

Are you experiencing any of these symptoms? 3, 4

  • Fatigue (present in 68-83% of untreated patients)
  • Weight gain (24-59%)
  • Cold intolerance
  • Cognitive issues: memory loss, difficulty concentrating (45-48%)
  • Constipation
  • Dry skin
  • Hair loss
  • Menstrual irregularities: heavy or irregular periods (23%)
  • Voice changes

Signs of Overtreatment (Thyrotoxicosis)

Have you noticed any of these symptoms? 2

  • Rapid or irregular heartbeat
  • Chest pain
  • Shortness of breath
  • Tremors
  • Nervousness or irritability
  • Sleeplessness
  • Excessive sweating
  • Heat intolerance
  • Unintentional weight loss
  • Diarrhea
  • Leg cramps

Critical warning: Overtreatment increases cardiovascular risks (atrial fibrillation, heart failure) and accelerates bone loss in postmenopausal women 1

Comorbidities and Special Circumstances

Cardiovascular Disease

  • Do you have any heart problems? Specifically:
    • Coronary artery disease
    • History of angina
    • Atrial fibrillation
    • Heart failure

If present, monitor for anginal symptoms as levothyroxine can exacerbate cardiac conditions 1

Diabetes

  • Do you have diabetes? If yes:
    • Are you monitoring blood glucose levels?
    • Have you noticed changes in glucose control?

Hypothyroidism can cause insulin resistance and hyperglycemia 3

Pregnancy Status

For women of childbearing age:

  • Are you pregnant or planning pregnancy? 1

    • Levothyroxine requirements increase by approximately 30% during pregnancy
    • TSH should be measured immediately upon conception
    • Goal TSH: <2.5 mIU/L in first trimester, <3.0 mIU/L in second trimester, <3.5 mIU/L in third trimester
  • Are you breastfeeding?

Other Medical Conditions

  • Do you have adrenal insufficiency or pituitary problems?

    • Adrenal insufficiency must be treated before or concurrent with levothyroxine to prevent adrenal crisis 1
  • Are you taking anticoagulants (blood thinners)?

    • Clotting status requires frequent monitoring 2

Recent Changes Requiring Dose Adjustment

Weight Changes

  • Have you had significant weight loss or gain recently? 1
    • Weight loss decreases levothyroxine requirements
    • Dosing is based on lean body mass

Age Considerations

  • For patients >50-60 years: 1
    • Elderly patients require 20-25% less levothyroxine per kilogram than younger patients
    • Are you experiencing any cardiac symptoms?

New Medications

  • Have you started any new medications in the past 2-3 months?
    • TSH should be rechecked 4-8 weeks after starting drugs that affect levothyroxine absorption or metabolism 1

Upcoming Surgery

  • Do you have any planned surgeries?
    • Physician/dentist should be notified of levothyroxine use 2

Monitoring and Follow-up

Laboratory Testing History

  • When was your last TSH level checked?

    • Should be monitored 6-8 weeks after dose changes 1
    • Once stable, check every 6-12 months 1
  • Do you know your most recent TSH value?

    • Goal for most non-pregnant adults: TSH within normal reference range (generally 0.4-4.0 mIU/L) 1

Treatment Duration and Response

  • How long have you been on this dose?

    • It may take several weeks to notice symptom improvement 2
    • Some manifestations (chronic skin changes) may take 3-6 months to resolve 1
  • Have you noticed improvement in your symptoms since starting or adjusting levothyroxine?

Red Flags Requiring Immediate Attention

Seek immediate medical care if experiencing: 3, 4

  • Severe chest pain or palpitations
  • Extreme fatigue with confusion or altered mental status (possible myxedema coma)
  • Hypothermia
  • Severe hypotension
  • Respiratory distress

Clinical Pitfall: Patients with persistent symptoms despite normal TSH should be evaluated for non-compliance, absorption issues, drug interactions, or alternative diagnoses rather than empirically increasing the dose 1. The most common cause of inadequate control is non-compliance, not true treatment resistance 1.

References

Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Research

Hypothyroidism: A Review.

JAMA, 2025

Research

Hypothyroidism: Diagnosis and Treatment.

American family physician, 2021

Related Questions

What is the appropriate management for a patient taking levothyroxine 75 µg who has a thyroid‑stimulating hormone (TSH) level of 10 mIU/L?
Should levothyroxine be started in a female patient with constant fatigue and sleepiness who has a thyroid‑stimulating hormone level of 4.5 mIU/L?
Should a thyroid‑stimulating hormone level of 5.13 mIU/L be treated with levothyroxine?
In an adult patient with subtherapeutic thyroid‑stimulating hormone (TSH), how often can levothyroxine be increased?
What is the appropriate management for a patient with a thyroid‑stimulating hormone level of 28 mIU/L while taking levothyroxine 50 µg daily?
For a 76‑year‑old patient with type 2 diabetes mellitus on metformin 1000 mg daily and an HbA1c of 6.8 %, should the current regimen be continued or adjusted?
How should I adjust the regimen for a patient with elevated blood pressure who is already taking lisinopril 20 mg daily, furosemide (Lasix) 20 mg daily, metoprolol extended‑release 12.5 mg daily, amiodarone 100 mg daily, and hydralazine 25 mg twice daily?
In a patient with an estimated glomerular filtration rate of 46.6 mL/min/1.73 m² (stage 3 chronic kidney disease) who is taking lisinopril 20 mg daily, furosemide 20 mg daily, metoprolol extended‑release 12.5 mg daily, and hydralazine 25 mg twice daily, how should these medications be managed or adjusted?
What antibiotics are safe for treating mastitis in a breastfeeding mother?
How often should QT interval monitoring be performed in adults over 65, females, or patients with cardiac disease, electrolyte disturbances, or concurrent QT‑prolonging drugs when they are started on neuropsychiatric medications that can prolong QT?
Is it safe to increase his lisinopril dose in a patient with an estimated glomerular filtration rate of 46.6 mL/min/1.73 m²?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.